MoneyWorks4Me

Cipla informs about analyst meet

04 Feb 2022 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it attached schedule of Analyst / Institutional Investor Meetings with the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1755.20
Dr. Reddys Labs. 1233.00
Cipla 1326.10
Lupin 1965.75
Zydus Lifesciences 1113.95
View more..